Predictors of survival in patients with recurrent malignant pleural effusion Source: Annual Congress 2008 - Diagnostic and therapeutic approaches in pleural diseases Year: 2008
Retrospective analysis of nontuberculosis pleural effusion cases Source: Eur Respir J 2006; 28: Suppl. 50, 579s Year: 2006
The association between pleural fluid exposure and survival in malignant pleural mesothelioma: a retrospective cohort study in 761 patients Source: Virtual Congress 2020 – Malignant pleural effusion in 2020: understanding the biology and clinical implications Year: 2020
Retrospective analysis of 455 pleural effusions Source: Eur Respir J 2005; 26: Suppl. 49, 447s Year: 2005
Survival time in patients with malignant pleural mesothelioma Source: Annual Congress 2007 - Rare tumours, risk factors and epidemiology in thoracic oncology Year: 2007
Survival after intrapleural catheter (IPC) insertion for malignant pleural effusion (MPE): a retrospective audit of prognostic scoring tools in patients with MPE treated with an IPC in a district general hospital. Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer Year: 2020
Histology, performance status and lymphopenia are factors of survival in patients undergoing thoracoscopy for malignant pleural effusion Source: Annual Congress 2009 - Trends in bronchoscopy Year: 2009
Pleurodesis after intrapleural catheter insertion is an independent factor for overall survival in patients with malignant pleural effusions Source: Annual Congress 2009 - New insights in biology and treatment of pleural tumours Year: 2009
Thoracoscopic evaluation of the effect of tumour burden on the outcome of pleurodesis in malignant pleural effusion Source: Virtual Congress 2021 – Pleural disease and bronchoscopic lung volume reduction Year: 2021
An analysis of indwelling pleural catheter (IPC) insertions for malignant pleural effusions Source: Annual Congress 2011 - Pleural and mediastinal malignancies: management and rare clinical cases Year: 2011
Retrospective assessment of diagnostic yield of percutaneous transthoracic pleural biopsy in malignant pleural effusions Source: Eur Respir J 2004; 24: Suppl. 48, 528s Year: 2004
Predictors of successful pleurodesis for patients with malignant pleural effusions Source: Eur Respir J 2004; 24: Suppl. 48, 493s Year: 2004
Blind pleural biopsy in the study of undiagnosed pleural effusion: results and complications Source: Virtual Congress 2020 – Interventional pulmonology: the pleura and bronchoscopic treatment of emphysema Year: 2020
Improving the tuberculous and malignant pleural effusions diagnosis. A low cost model based on a multivariate analysis Source: Eur Respir J 2004; 24: Suppl. 48, 82s Year: 2004
Survival of patients with malignant pleural effusions: a three-year prospective self-experience study Source: International Congress 2018 – Clinical management of pleural malignancies, including mesothelioma Year: 2018
Extrapleural pneumonectomy versus pleurectomy/decortication in malignant pleural mesothelioma: an updated meta-analysis of survival endpoints Source: International Congress 2019 – All aspects of general thoracic surgery Year: 2019
Mortality among patients with pleural effusion undergoing thoracentesis Source: Eur Respir J 2015; 46: 495-502 Year: 2015
Intrahospital mortality after pleurodesis for malignant pleural effusion Source: Eur Respir J 2004; 24: Suppl. 48, 629s Year: 2004
A randomised controlled study to compare the efficacy of closed pleural biopsy and medical thoracoscopic pleural biopsy in undiagnosed exudative pleural effusion Source: Annual Congress 2011 - From outside to inside: access to the pleura Year: 2011
Malignant pleural mesothelioma (MPM): clinical presentation, complications and survival Source: Eur Respir J 2002; 20: Suppl. 38, 272s Year: 2002